Biologists have long attempted by chemical means to induce in higher organisms predictable and specific changes which thereafter could be transmitted in series as hereditary characters. Among micro6rganisms the most striking example of inheritable and specific alterations in cell structure and function that can be experimentally induced and are reproducible under well defined and adequately controlled conditions is the transformation of specific types of Pneumococcus. This phenomenon was first described by Griflith (1) who succeeded in transforming an attenuated and non-encapsulated (R) variant derived from one specific type into fully encapsulated and virulent (S) cells of a heterologous specific type. A typical instance will suffice to illustrate the techniques originally used and serve to indicate the wide variety of transformations that are possible within the limits of this bacterial species.
Griflith found that mice injected subcutaneously with a small amount of a living R culture derived from Pneumococcus Type II together with a large inoculum of heat-kitled Type III (S) cells frequently succumbed to infection, and that the heart's blood of these animals yielded Type III pneumococci in pure culture. The fact that the R strain was avirulent and incapable by itself of causing fatal hacteremia and the additional fact that the heated suspension of Type III cells contained no viable organisms brought convincing evidence that the R forms growing under these conditions had newly acquired the capsular structure and biological specificity of Type HI pneumococci.
The original observations of Griflith were iater confirmed by Neufeld and Levinthai (2) , and by Baurbenn (3) abroad, and by Dawson (4) in this iaboratory. Subsequently Dawson and Sia (5) succeeded in inducing transformation is ~ro. This they accomplished by growing R cells in a fluid medium containing anti-R serum and heat-killed encapsulated S cells. They showed that in the test tube as in the animal body transformation can be selectively induced, depending on the type specificity of the S cells used in the reaction system. Later, Alloway (6) (3) . The interest in this turning point in biology continues to grow, and Dr. McCarty is asked frequently to retell his part in lectures all over the world. So, on this golden anniversary, we have invited him to share with us an even more personal version, one focused on the highlights of the firml critical years of the DNA project. His account, including facsimile pages from lab notebooks, is taken from a lecture he delivered at the time of the 35th anniversary. It is a timeless piece, and we are delighted to be able to publish it here.
The 50th anniversary of the Avery, MacLeod, and McCarty paper calls for a triple tribute. The tribute is not only to a great moment in science, but also to a model of the fruits of experimental medicine and to the scholars who secured the historic findings.
The Study of Pneumococeal Pneumonia: The Fruits of Experimental Medicine
The research endeavor we celebrate this month culminated a 30-year effort by the Avery Lab in The Rockefeller Hospital to understand and combat pneumococcal pneumonia. Historians might trace the lab's research for this classic paper to 1928, when Frederick Gri~th in London reported a startling observation that serological types of pneumococci were interchangeable (4). However, as Rent Dubos, a member of Avery's lab, describes so clearly in his biography of Oswald Avery, the pnenmococcus was his microcosm for at least 15 years prior to Griflith (5) . Beginning in 1913, Avery spent four years studying the types and prevalence of pneumococci in patients and in carriers, and he processed the serum used to treat patients with type I lobar pneumonia. In 1917, Avery was senior author of a monograph that describes all that had been learned from practical experience with this disease in The Rockefeller Hospital (6) . According to Dubos, Avery soon realized that the diagnosis and treatment ofpnenmonia required "detailed knowledge of the pneumococcal cell itself, of its structure, its chemical composition, its physiological activities, its immunological characteristics, its genetic stability and variability" (5, p. 88). The Avery Lab then made a systematic study of the pneumococcus. In particular, the knowledge amassed on this organism's capsule before 1928 was integral to the lab's crowning revelation about DNA in 1944. Some of these early findings, detailed by Dubos (5), are summarized in Table 1 . 4 . Antibodies produced against the capsular polysaccharides protect against pneumococcal infection by neutralizing the antiphagocytic property of the capsules. The protection is specific for each pneumococcal type (this work showed for the fast time that molecules other than proteins could elicit antibody responses). 5. An enzyme destroys the capsule of one type of pneumococci and can be used to cure animals suffering from an experimental infection with this organism.
Avery, not surprisingly, became convinced that the phenomenon recognized by Gritfith would yidd a biological clue as to how the pneumococcus controlled the formation of its critical capsule. It is of interest, as Dubos notes, that from 1928 until the 1944 paper, the Avery Lab, "seemingly unaffected by outside influences .... was the only place where research was conducted" on the transformation phenomenon (5, p. 225). A critical aspect of Gritfith's phenomenon was that it took place in mice. Several efforts that are described here by McCarty resulted in a reproducible, quantitative, ex vivo approach to transformation, and ultimately the historic chemical characterization of the transforming substance as a highly polymerized viscous form of DNA.
Avery could not have predicted that DNA was itself the genetic material when he committed his laboratory to the study of pneumococcal pneumonia 30 years before. During this period, most of the scientific reasoning considered genes to be proteins. It even was not appreciated that the pnenmococcus contained DNA. Yet, as Joshua Lederberg acknowledged, the experiments reported in 1944 would not have been "performed except in the context of a clinical observation." In the setting of a medical investigation into the causes of pneumonia, Lederberg observed that "the tools were there: background information, natural and historical information about the pneumococcus" (7). Very likely, major advances in experimental medicine will continue to require comparably long investments of time, talent, and facilities such as those made by the Avery Lab in the context of The Rockefeller Hospital
The Discovery: The Onset of the DNA Revolution
The 1944 paper in the Journal has been called "a model of factual statement and careful analysis" (8, p. 147). The paper contains and discusses the revolutionary evidence that DNA is the transforming principle and influences the capsule of the pneumococcus in a heritable way. The summary and conclusion are reproduced as Table 2 . 
CONCLUSION
The evidence presented supports the belief that a nucleic acid of the desoxyribose type is the fundamental unit of the transforming principle of Pneumococcus Type Ill.
What follows are several excerpts from that great moment in science. The paper's opening words articulate the authors' keen awareness of the significance of the new information they were relating. "Biologists have long attempted by chemical means to induce in higher organisms predictable and specific changes which thereafter could be transmitted in series as hereditary characters. Among microorganisms the most striking example of inheritable and specific alterations in cell structure and function that can be experimentally induced and are reproducible under weU defined and adequately controlled conditions is the transformation of specific types of Pneumococcus" (1, p. 137).
The critical feature of the rough to smooth (R to S) transformation system, illustrated in Fig. 1 , is emphasized early: "Transformation of [pneumococcal] types has never been observed to occur spontaneously and has been induced e~erimen-tally only by the special techniques outlined earlier in this paper" (1, p. 140) .
The Discussion places the discovery in a setting which still seems remarkable for those of us who grew up knowing that DNA is the genetic material. "So far as the writers are aware, however, a nucleic acid of the desc~ribose type has not heretofore been recovered from pneumococci nor has the specific transformation been experimentally induced in vitro by a chemicaUy defined substance" (1, p. 152).
Avery, MacLeod, and McCarty focus on their evidence. "The inducing substance, on the basis of its chemical and physical properties, appears to be a highly polymerized and viscous form of sodium desoxyribonudeate. On the other hand, the Type III capsular substance, the synthesis of which is evoked by this transforming agent, consists chiefly of a non-nitrogenous polysaccharide .... Thus it is evident that the inducing substance and the substance produced in turn are chemically distinct and biologically specific in their action and that both are requisite in determining the type specificity of the cell of which they form a part. The experimental data presented in this paper strongly suggest that nucleic acids, at least those of the desoxyribose type, possess different specificities as evidenced by the selective action of the transforming principle" (1, p. 152).
The Discussion then moves to thoughts on mechanism. The authors point out that "In the present state of knowledge any interpretation of the mechanism involved in transformation must of necessity be purely theoretical .... Once transformation has occurred, the newly acquired characteristics are thereafter transmitted in series through innumerable transfers in artificial media without any further addition of the transforming agent. Moreover, from the transformed ceUs themselves, a substance of identical activity can again be recovered in amounts far in excess of that originally added to induce the change. It is evident, therefore, that not only is the capsular material reproduced in successive generations but that the primary factor which controls the occurrence and specificity of capsular development, is also reduplicated in the daughter ceUs" (1, p. 154) .
The authors next stress the impact of their findings beyond the Lab's preoccupation with the pneumococcus. "It is particularly significant in the case of pneumococci that the experimentally induced alterations are definitely correlated with the development of a new morphological structure and the consequent acquisition of new antigenic and invasive properties. Equally ff not more significant is the fact that these changes are predictable, type-specific, and heritable .... More recently the phenomenon has been interpreted from a genetic point of view. The inducing substance has been likened to a gene, and the capsular antigen which is produced in response to it has been regarded as a gene product" (1, p.
154-155).
This evaluation leads to their concluding paragraph on the biological specificity of DNA. "It is, of course, possible that the biological activity of the substance described is not an inherent property of the nucleic acid but is due to minute amounts of some other substance adsorbed to it or so intimately associated with it as to escape detection. If, however, the biologically active substance isolated in highly purified form as the sodium salt of desoxyribonucleic acid actually proves to be the transforming principle, as the available evidence strongly suggests, then nucleic acids of this type must be regarded not merely as structurally important but as functionally active in determining the biochemical activities and specific characteristics of pneumococcal cells . . . . If the results of the present study on the chemical nature of the transforming principle are confirmed, then nudeic acids must be regarded as possessing biological specificity the chemical basis of which is as yet undetermined" (1, p. 155).
The findings in the 1944 paper were quickly confirmed and extended. Robert Olby's book, The Path to the Double Helix (9), perhaps best outlines the impact. Notable were the findings of Andr6 Boivin and Roger Vendrely in France, which led to their rule describing the constancy of DNA per cell and its halving in germ cell formation, and the demonstrations by Erwin Chargaff at Columbia University that DNA contents were different in different organisms but that there were equimolar amounts of the bases T:A and G:C in each case.
The post-1944 years at Rockefeller are described by RoUin Hotchkiss, another key member of Avery's group. Hotchkiss, among his many achievements, performed additional chemical studies of the transforming principle, and he used transformation to induce genetic changes such as drug resistance in pneumococci (10) . McCarty himself soon purified a DNase from beef pancreas (11) and showed that the enzyme effidently inactivated the transforming principle (12) , something that depolymerases for protein, RNA, and polysaccharide previ-Editorial Figure 1 . Colonies ofpneumococci on the surface of blood agar. This is the picture used in the 1944 paper. The small colonies on the left are the rough (R) unencapsuhted strain derived from type II pneumococci. The smooth (S) glistening colonies on the right are of the same strain after transformation with DNA from type III. They have capsules of type III polysaccharide, x 3.5.
ously had failed to do (1) . This allowed McCarty to write, "The possibility has been recognized that the activity of the transforming agent might be referable to minute amounts of some other substance such as protein in the purified preparations. The results of the present investigation show that in order to detect proteolytic activity, it is necessary to use an amount of purified desoxyribonuclease 100,000 times greater than that required to cause rapid and complete destruction of activity of the transforming substance . . . . The objection can be raised that the nucleic acid may merely serve as a 'carrier' for some hypothetical substance, presumably protein, which possesses the specific transforming activity.... There is no evidence in favor of such a hypothesis, and it is supported chiefly by the traditional view that nucleic acids are devoid of biological specificity. On the contrary, there are indications that even minor disruptions in the long-chain nucleic acid molecule have a profound effect on biological activity" (12, p. 94).
McCarty again emphasizes the genetic impact. "In all probability only a relatively small number of the total molecules in an active preparation of desoxyribonucleate from Pneumococcus Type III are capable of inducing transformation. This is suggested by the fact that extraction of unencapsuluted R pneumococci yields a similar desoxyribonucleate fraction that at present can be distinguished from the Type III material only by the fact that the former is inactive in the transforming system. It is possible that the nucleic acid of the R pneumococcus is concerned with innumerable other functions of the bacterial cell, in a way similar to that in which capsular development is controlled by the transforming substance. The desoxyribonucleic acid from Type III pneumococci would then necessarily comprise not only molecules endowed with transforming activity, but in addition a variety of others which determine the structure and metabolic activities possessed in common by both the encapsulated (S) and unencapsulated (R) forms. If these considerations have any foundation in fact, the task of discovering the chemical basis of biological spedfidty of desoxyribonucleic acids becomes extremely complex, since a given preparation will represent a mixture of a large number of entities of diverse specifidty" (12, p. 95).
